MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/bloodadvances.2022008042

Медицинская библиотека · Blood advances · 2023

Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study.

Gagelmann Nico, Wulf Gerald Georg, Duell Johannes, Glass Bertram, van Heteren Pearl, von Tresckow Bastian, Fischer Monika, Penack Olaf, Ayuk Francis, Einsele Herrmann, Holtick Udo, Thomson Julia, Dreger Peter, Kröger Nicolaus

СтатьяПеревод пока не подготовлен

Аннотация

Hematotoxicity after chimeric antigen receptor (CAR) T-cell therapy is associated with infection and death but management remains unclear. We report results of 31 patients receiving hematopoietic stem cell boost (HSCB; 30 autologous, 1 allogeneic) for either sustained severe neutropenia of grade 4 (<0.5 × 109/L), sustained moderate neutropenia (≤1.5 × 109/L) and high risk of infection, or neutrophil count ≤2.0 × 109/L and active infection. Median time from CAR T-cell therapy to HSCB was 43 days and median absolute neutrophil count at time of HSCB was 0.2. Median duration of neutropenia before HSCB was 38 days (range, 7-151). Overall neutrophil response rate (recovery or improvement) was observed in 26 patients (84%) within a median of 9 days (95% confidence interval, 7-14). Time to response was significantly associated with the duration of prior neutropenia (P = .007). All nonresponders died within the first year after HSCB. One-year overall survival for all patients was 59% and significantly different for neutropenia (≤38 days; 85%) vs neutropenia >38 days before HSCB (44%; P = .029). In conclusion, early or prophylactic HSCB showed quick response and improved outcomes for sustained moderate to severe neutropenia after CAR-T.

Для цитирования: Gagelmann Nico, Wulf Gerald Georg, Duell Johannes, Glass Bertram, van Heteren Pearl, von Tresckow Bastian, Fischer Monika, Penack Olaf, Ayuk Francis, Einsele Herrmann, Holtick Udo, Thomson Julia, Dreger Peter, Kröger Nicolaus. Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study.. Blood advances. 2023. DOI: 10.1182/bloodadvances.2022008042.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.